Sweden· SE-19761001000014
Glucos Fresenius Kabi 100 mg/ml Infusionsvätska, lösning
A medicinal product containing glucose, registered in Sweden by Fresenius Kabi AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Glucose
- Manufacturer
- Fresenius Kabi AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19761001000014
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glucose in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGLUCOSE FRESENIUS KABI 10%Fresenius Kabi s.r.o., Praha
- FinlandGlucos B. BraunB. Braun Melsungen AG
- PolandGlucosum 10% FreseniusFresenius Kabi Polska Sp. z o.o.
- IcelandGlucos Baxter ViafloBaxter Medical AB*
- NorwayGlucos Fresenius KabiFresenius Kabi Norge AS
- BelgiumGlucose Sterop 100 mg/mlLaboratoires Sterop
- United KingdomAACE Gluco 40% gelEssential-Healthcare Ltd
- SwitzerlandGlucose 5 % B. Braun, InfusionslösungB. Braun Medical AG
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Glucose B. Braun, Glucose Fresenius
- Belgium · Glucose Aguettant, Glucose B. Braun
- Bulgaria · Глюкоза Бакстер, Глюкоза Браун
- Cyprus · Dextrose /Demo 20%, Dextrose Demo
- Czechia · Ardeanutrisol G, Glucose Fresenius Kabi
- Germany · Glucose B. Braun, Glucose Laboratoire Aguettant
- Denmark · Glucos B. Braun, Glucos Fresenius Kabi
- Estonia · Glucose B. Braun, Glucose B.Braun
- Spain · Dextrosa Fresenius Kabi, Freeflex Glucosa
- Finland · Glucos B. Braun, Glucos Fresenius Kabi
- France · Glucose Aguettant, Glucose B. Braun
- United Kingdom (Northern Ireland) · Glucose Aguettant, Glucose B. Braun Melsungen
- Greece · Dextrose Cooper, Dextrose Fresenius
- Croatia · Glukoza B. Braun, Glukoza Fresenius Kabi
- Hungary · Glucose B. Braun, Glucosum Pannonpharma
- Ireland · Glucose, Glucose Baxter Holding
- Iceland · Glucos Fresenius Kabi, Glucos Viaflo Baxter
- Italy · Glucorange, Glucosio
- Lithuania · Glucose B. Braun, Glucose B.Braun
- Luxembourg · Glucose, Glucose B. Braun
- Latvia · Glucose B.Braun, Glucose Fresenius
- Malta · Dextrose Vioser, Glucose Baxter Holding
- Netherlands · Glucose, Glucose 5% G/V
- Norway · Glucos B. Braun, Glucos Fresenius Kabi
- Poland · Gluco Test, Glucosi Baxter
- Portugal · Glucosada, Glucosada Grifols
- Romania · Dextrose Vioser, Glucose B Braun
- Slovenia · Glukoza Baxter, Glukoza Braun
- Slovakia · Glucose Fresenius Kabi, Glucose Intravenous Infusion B.P. Bieffe
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3ab076cf-8940-4fb7-aba5-4e35c0ae49b0 GET /v1/drugs/3ab076cf-8940-4fb7-aba5-4e35c0ae49b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19761001000014",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19761001000014",
"product_doc_link": "https://docetp.mpa.se/LMF/Glucos%20Fresenius%20Kabi%20solution%20for%20infusion%20SmPC_09001bee807a3cce.pdf"
}See everything about glucose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.